News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
News
The latest business, scientific & regulatory news from the pharmaceutical and biotechnology industries. Trends & international news from global correspondents and breakthroughs in research in Coming Down the Pike.

Right first time drug manufacture

November 20, 2009

Pharmaceutical Technology Europe

Engineers at a UK university claim to have developed technology that can be used in existing chemical reactors to ensure right first time drug crystal formation, which is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations.

Fifty Percent of MS Patients Avoid Treatment Over Injectable Delivery Fears

November 19, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Around half of all multiple sclerosis (MS) patients that are eligible for treatment do not receive it and one in five of those patients that do begin therapy, delay doing so because of fear and anxiety over the treatment process, and not fear and anxiety about the disease.

GSK Donates Influenza A (H1N1) Vaccine to WHO

November 19, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Last week, GlaxoSmithKline (GSK, London) agreed to donate 50 million doses of its adjuvanted pandemic influenza A (H1N1) vaccine to the World Health Organization (WHO).

Rx-360 Takes on Europe, Talks to PharmTech About Shared Audits

November 19, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

The international pharmaceutical supply-chain consortium Rx-360 held a launch meeting in Europe last week with more than 135 industry and regulatory representatives in attendance.

Pfizer Announces R&D Facility Consolidation

November 19, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Following the its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York) Pfizer detailed plans for its global research and development (R&D) network, which includes consolidation of its R&D facilities.

Novartis Updates Vaccine Progress in Germany; Acquires Chinese Vaccine Manufacturer

November 12, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novartis reported that German regulatory authorities approved its adjuvanted cell culture-based Influenza A (H1N1) 2009 monovalent vaccine, Celtura. The company also said it will acquire a stake in Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical.

EU Issues Strategy for Influenza A (H1N1) Vaccine Benefit–Risk Monitoring

November 12, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency, the European Center for Disease Prevention and Control, and the Heads of Medicines Agencies issued a European strategy for H1N1 vaccine benefit–risk monitoring.

PhRMA Reacts to House Healthcare-Reform Bill

November 12, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

On Sunday, Nov. 8, 2009, the Pharmaceutical Research and Manufacturers of America (PhRMA) expressed its disappointment with the US House of Representatives's healthcare-reform bill.

AAPS Announces Annual Awards, Names 2009 Fellows

November 12, 2009
ePT--the Electronic Newsletter of Pharmaceutical Technology

The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week.

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
26%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
58%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Click here